1216183

Fresenius Kabi USA LLC — FEI 1450022

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed